Bao YS - Search Results

1

Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease.

Bao YS, Ji Y, Zhao SL, Ma LL, Xie RJ, Na SP. Bao YS, et al. Biomarkers. 2013 Aug;18(5):379-85. doi: 10.3109/1354750X.2013.790074. Epub 2013 May 7. Biomarkers. 2013. PMID: 23651343

2

The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2.

Bao YS, Zhang P, Xie RJ, Wang M, Wang ZY, Zhou Z, Zhai WJ, Feng SZ, Han MZ. Bao YS, et al. Int Immunopharmacol. 2011 Oct;11(10):1599-605. doi: 10.1016/j.intimp.2011.05.021. Epub 2011 May 31. Int Immunopharmacol. 2011. PMID: 21635971

3

An evaluation of the RIFLE criteria for acute kidney injury after myeloablative allogeneic haematopoietic stem cell transplantation.

Bao YS, Xie RJ, Wang M, Feng SZ, Han MZ. Bao YS, et al. Swiss Med Wkly. 2011 Jul 18;141:w13225. doi: 10.4414/smw.2011.13225. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21769755 Free article.

4

Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease.

Bao YS, Na SP, Zhang P, Jia XB, Liu RC, Yu CY, Mu SH, Xie RJ. Bao YS, et al. J Clin Immunol. 2012 Jun;32(3):587-94. doi: 10.1007/s10875-011-9622-7. Epub 2011 Dec 28. J Clin Immunol. 2012. PMID: 22203232

5

Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.

Bao YS, Na SP, Jia XB, Liu RC, Wang MA, Yu CY, Mu SH, Xie RJ. Bao YS, et al. Curr Med Res Opin. 2012 Mar;28(3):379-84. doi: 10.1185/03007995.2012.661708. Epub 2012 Feb 16. Curr Med Res Opin. 2012. PMID: 22335251

6

Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.

Wang M, Xie R, Liu R, Jia X, Bao Y, Liu X. Wang M, et al. Endocrine. 2012 Oct;42(2):329-34. doi: 10.1007/s12020-012-9630-2. Epub 2012 Mar 7. Endocrine. 2012. PMID: 22396142

7

Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors.

Zou C, Xie R, Bao Y, Liu X, Sui M, M S, Li S, Yin H. Zou C, et al. Endocrine. 2013 Dec;44(3):666-74. doi: 10.1007/s12020-013-9907-0. Epub 2013 Mar 7. Endocrine. 2013. PMID: 23468095

8

Epidemiology and risk factors for chronic kidney disease in patients with ischaemic stroke.

Bao YS, Song LT, Zhong D, Song AX, Jia XB, Liu RC, Xie RJ, Na SP. Bao YS, et al. Eur J Clin Invest. 2013 Aug;43(8):829-35. doi: 10.1111/eci.12113. Epub 2013 Jun 12. Eur J Clin Invest. 2013. PMID: 23869408

9

Characterization of soluble thrombomodulin levels in patients with stage 3-5 chronic kidney disease.

Bao YS, Jia XB, Wang D, Liu RC, Zou CB, Na SP. Bao YS, et al. Biomarkers. 2014 Jun;19(4):275-80. doi: 10.3109/1354750X.2014.904000. Biomarkers. 2014. PMID: 24854597

10

Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.

Wang Y, Li SS, Na SP, Yu CY, Ji Y, Zhao SL, Xie RJ, Bao YS. Wang Y, et al. Among authors: bao ys. Am J Med Sci. 2016 Oct;352(4):348-353. doi: 10.1016/j.amjms.2016.07.002. Epub 2016 Jul 14. Am J Med Sci. 2016. PMID: 27776715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters